MolecularHealth Opens New Office In Boston

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MolecularHealth Expands its Footprint with New Office in Boston Metro Area

THE WOODLANDS, Texas & NEWTON, Mass.--(BUSINESS WIRE)-- MolecularHealth announced today that it has opened a new office in the greater Boston metro area, at the Riverside Center in Newton, Mass. Run by Chief Commercial Officer Laura Housman, the Boston location will house members of the company’s commercial and business development teams, among others.

“Boston is a hotbed of cutting-edge science, and a major biotech hub,” said Housman. “As we work towards generating adoption of our oncology treatment decision support offering over the coming months, it’s important that we have a presence in Boston, where many of our current and potential partners and customers are located.”

Dr. Lloyd Everson, CEO of MolecularHealth, added, “As we get closer to the official launch of our next generation sequencing and TreatmentMAP™ service offering to oncologists, pathologists and the biopharma industry, we are continuing to add key personnel and build out our infrastructure. A physical location in the Boston area was a logical next step for the company, and I look forward to additional growth as we enter the market.”

MolecularHealth recently announced the opening of its U.S. headquarters and clinical lab, co-located in The Woodlands, Texas. Following a number of key new hires to its executive team in Texas, the company expects to fill several additional positions for its Boston office, including a marketing director and health economist.

ABOUT MOLECULARHEALTH

MolecularHealth delivers on the promise of personalized, precision medicine. By using advanced proprietary information technologies to sift through terabytes of genetic and molecular test findings in a fraction of the time needed for current manual analysis, MolecularHealth provides doctors and patients with faster, more accurate insights into the role genes play in the progression and treatment of an individual’s cancer. Eight years in development by a multidisciplinary team of doctors, scientists and IT experts, MolecularHealth works in partnership with some of the world’s leading healthcare and information technology companies, including the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). The company has headquarters in The Woodlands, Texas and Heidelberg, Germany. Visit www.molecularhealth.com for more information.

Contact:
Gregory FCA
Jessica Attanasio
Associate Vice President
610-228-2112
Jessica@GregoryFCA.com

Help employers find you! Check out all the jobs and post your resume.

Back to news